Protein anabolism is key to long-term survival in high-grade serous ovarian cancer

被引:7
|
作者
Wang, Lingxiang [1 ,2 ,3 ]
Sun, Tao [4 ]
Li, Shumei [2 ,3 ]
Zhang, Zhengmao [1 ,2 ]
Jia, Jingde [1 ,2 ]
Shan, Baoen [2 ,3 ]
机构
[1] Hebei Med Univ, Affiliated Hosp 4, Dept Gynecol, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
[2] Hebei Prov Tumor Hosp, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
[3] Hebei Med Univ, Affiliated Hosp 4, Canc Inst, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
[4] Hebei Med Univ, Affiliated Hosp 3, Dept Orthopaed Surg, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 01期
关键词
Ovarian cancer; Long-tenn survivor; Protein anabolism; Gene expression profiling; PREOPERATIVE SERUM-ALBUMIN; EXPRESSION SIGNATURE; FUNCTIONAL-ANALYSIS; GENE; POMC; PROOPIOMELANOCORTIN; BIOMARKERS; CARCINOMA; WOMEN;
D O I
10.1016/j.tranon.2020.100885
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to identify the biological processes associated with long-term survival in high-grade serous ovarian cancer (HGSOC). HGSOC cases obtained from The Cancer Genome Atlas Ovarian Cancer (TCGA-OV) database were divided into long-term survivors (ITS) and normal-term survivors (NTS) based on survival cutoffs defined by the HGSOC cohort in the SEER database. Differentially expressed genes (DEGs) were screened using the generalized linear modeling (GLM) method. Gene Ontology (GO) functional and KEGG pathway enrichment analyses were performed using DAVID Bioinformatics Resources. DEG-related protein-protein interactions (PPI) were extracted from the STRING database and hub genes were identified using Cytol lubba in the Cytoscape program. In total, 157 DEGs, including 155 unregulated and 2 downregulated genes, were identified. Unregulated genes were statistically enriched in 80 GO terms and 11 KEGG pathways related to energy and substrate metabol ism, such as protein absorption, digestion, and metabolism as well as signaling pathways, including chromatin silencing, regulation of ERKI and ERK2 cascade, and regulation of MAPKKK. ALB and POMC were the common hub genes. These findings reveal that protein anabolism is crucial to long-term survival, regulated by activation of the MAPK/ERK signaling pathway and chromatin silencing. Comprehensive understanding of the molecular mechanisms via further exploration may contribute toward an effective treatment for ovarian cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] What influences the long-term survival of advanced high-grade serous ovarian cancer?
    Xie, X.
    Jin, L.
    Tang, S.
    Shen, Y.
    Cheng, X.
    Lv, W.
    Wan, X.
    Chen, Z.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 347 - 347
  • [2] Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients
    Clarke, Christina L.
    Kushi, Lawrence H.
    Chubak, Jessica
    Pawloski, Pamala A.
    Bulkley, Joanna E.
    Epstein, Mara M.
    Burnett-Hartman, Andrea N.
    Powell, Bethan
    Pearce, Celeste L.
    Feigelson, Heather Spencer
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (05) : 996 - 999
  • [3] The genomic landscape of high-grade serous ovarian cancer in long-term survivors
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje C.
    Saner, Flurina
    Beach, Jessica A.
    Milne, Katy
    Kennedy, Catherine J.
    Hendley, Joy
    Traficante, Nadia
    Pearce, Celeste L.
    Pike, Malcolm C.
    Ramus, Susan J.
    Kobel, Martin
    Nelson, Brad H.
    Goode, Ellen L.
    deFazio, Anna
    Bowtell, David D.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer
    Fabbro, Michel
    Colombo, Pierre-Emmanuel
    Leaha, Cristina Marinella
    Rouanet, Philippe
    Carrere, Sebastien
    Quenet, Francois
    Gutowski, Marian
    Mourregot, Anne
    D'Hondt, Veronique
    Coupier, Isabelle
    Vendrell, Julie
    Vilquin, Paul
    Pujol, Pascal
    Solassol, Jerome
    Mollevi, Caroline
    [J]. CANCERS, 2020, 12 (08) : 1 - 14
  • [5] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Kennedy, Catherine J.
    Takahashi, Kazuaki
    Alsop, Kathryn
    Hamilton, Phineas T.
    Hendley, Joy
    Chiew, Yoke-Eng
    Traficante, Nadia
    Provan, Pamela
    Ariyaratne, Dinuka
    Au-Yeung, George
    Bateman, Nicholas W.
    Bowes, Leanne
    Brand, Alison
    Christie, Elizabeth L.
    Cunningham, Julie M.
    Friedlander, Michael
    Grout, Bronwyn
    Harnett, Paul
    Hung, Jillian
    McCauley, Bryan
    McNally, Orla
    Piskorz, Anna M.
    Saner, Flurina A. M.
    Vierkant, Robert A.
    Wang, Chen
    Winham, Stacey J.
    Pharoah, Paul D. P.
    Brenton, James D.
    Conrads, Thomas P.
    Maxwell, George L.
    Ramus, Susan J.
    Pearce, Celeste Leigh
    Pike, Malcolm C.
    Nelson, Brad H.
    Goode, Ellen L.
    DeFazio, Anna
    Bowtell, David D. L.
    [J]. NATURE GENETICS, 2022, 54 (12) : 1853 - 1864
  • [6] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Dale W. Garsed
    Ahwan Pandey
    Sian Fereday
    Catherine J. Kennedy
    Kazuaki Takahashi
    Kathryn Alsop
    Phineas T. Hamilton
    Joy Hendley
    Yoke-Eng Chiew
    Nadia Traficante
    Pamela Provan
    Dinuka Ariyaratne
    George Au-Yeung
    Nicholas W. Bateman
    Leanne Bowes
    Alison Brand
    Elizabeth L. Christie
    Julie M. Cunningham
    Michael Friedlander
    Bronwyn Grout
    Paul Harnett
    Jillian Hung
    Bryan McCauley
    Orla McNally
    Anna M. Piskorz
    Flurina A. M. Saner
    Robert A. Vierkant
    Chen Wang
    Stacey J. Winham
    Paul D. P. Pharoah
    James D. Brenton
    Thomas P. Conrads
    George L. Maxwell
    Susan J. Ramus
    Celeste Leigh Pearce
    Malcolm C. Pike
    Brad H. Nelson
    Ellen L. Goode
    Anna DeFazio
    David D. L. Bowtell
    [J]. Nature Genetics, 2022, 54 : 1853 - 1864
  • [7] Characterization of primary-metastasis pairs in high-grade serous ovarian cancer with short- and long-term survival
    Kotnik, E. N.
    Spies, N.
    Miller, C. A.
    Li, T.
    Inkman, M.
    Zhang, J.
    Guo, L.
    Maher, C.
    McCourt, C. K.
    Thaker, P. H.
    Hagemann, A. R.
    Mutch, D. G.
    Powell, M. A.
    Fuh, K. C.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 264 - 264
  • [8] Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis
    Baum, Joanna
    Braicu, Elena Ioana
    Hunsicker, Oliver
    Vergote, Ignace
    Concin, Nicole
    Van Nieuwenhuysen, Els
    Feldheiser, Aarne
    Achimas-Cadariu, Patriciu
    Darb-Esfahani, Silvia
    Berger, Astrid
    Fetica, Bogdan
    Mahner, Sven
    Papadia, Andrea
    Woelber, Linn
    Gasparri, Maria Luisa
    Vanderstichele, Adriaan
    Panici, Pierluigi Benedetti
    Mueller, Michael D.
    Ruscito, Ilary
    Woopen, Hannah
    Sehouli, Jalid
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (05) : 713 - 720
  • [9] Clinical features of long-term survivors with advanced high-grade serous ovarian cancer.
    Barretina-Ginesta, Maria-Pilar
    Bague, Anna Carbo
    Bujons, Elisabet
    Fortian, Arola
    Fina, Claudia
    Pardo, Marta
    Melendez-Munoz, Cristina
    Cardenas, Laura
    Taltavull, Anna
    Sabate, Josep
    Darder, Esther
    Feliubadalo, Lidia
    Barretina, Jordi
    Brunet, Joan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Who are the long-term survivors of high grade serous ovarian cancer?
    Hoppenot, Claire
    Eckert, Mark A.
    Tienda, Samantha M.
    Lengyel, Ernst
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (01) : 204 - 212